<ѻýҕl>Real-World Analysis Identifies Meds Tied to Higher Risk of Liver Injuryѻýҕl> Case reports may not be as reliable, researchers say Jun 25, 2024
<ѻýҕl>Court: Some Employers Can Exclude PrEP, Cancer Screenings From Insurance Coverageѻýҕl> Not all preventive care recommended by the USPSTF is threatened by the narrow ruling, however Jun 24, 2024
<ѻýҕl>Anti-PD-L1 Plus Targeted Agent No Better Than Chemo for Resistant NSCLCѻýҕl> No significant difference between atezolizumab-cabozantinib, docetaxel for OS, PFS, response Jun 20, 2024
<ѻýҕl>Early Menopause Tied to Higher Risk of Respiratory Mortalityѻýҕl> Greatest risk observed for women with bilateral oophorectomy Jun 13, 2024
<ѻýҕl>Another KRAS Inhibitor Scores an Early Win in Advanced Non-Small Cell Lung Cancerѻýҕl> Half of patients responded, but editorialists call for new directions in therapy development Jun 11, 2024
<ѻýҕl>Dendritic Cell Therapy Offers No Survival Advantage in Pleural Mesotheliomaѻýҕl> Immunotherapy may have been given too late, researchers suggested Jun 10, 2024
<ѻýҕl>Lung Cancer Screening Rates Remain Low in the U.S., Especially in the Southѻýҕl> But one study showed that patient navigation added to usual care may increase uptake Jun 10, 2024
<ѻýҕl>Artery Inflammation and CV Events; Stepped Palliative Care for Lung Cancer Patientsѻýҕl> Also in TTHealthWatch: diets and medicine in IBS and active surveillance in prostate cancer Jun 08, 2024 podcast
<ѻýҕl>Limited-Stage SCLC Gets a New Standard of Care With Consolidation Durvalumabѻýҕl> Median OS was 55.9 months in the durvalumab group compared with 33.4 months in the placebo group Jun 03, 2024
<ѻýҕl>'Practice Changing' Trial for Inoperable Locally Advanced NSCLCѻýҕl> EGFR testing now needed for all patients with stage III disease, experts say Jun 02, 2024
<ѻýҕl>Virtual and In-Person Palliative Care Equally Beneficial in Advanced Lung Cancerѻýҕl> No differences observed in quality of life metric, patient and caregiver satisfaction Jun 02, 2024
<ѻýҕl>Subcutaneous Amivantamab Plus Lazertinib Non-Inferior to IV Dosing in NSCLCѻýҕl> Unexpectedly offers a possible overall survival benefit, researchers say Jun 01, 2024
<ѻýҕl>Novel Bispecific in EGFR-Mutant Lung Cancer Boosts PFS After Targeted Agentsѻýҕl> China-based trial may present a hurdle to FDA approval, however Jun 01, 2024
<ѻýҕl>Unprecedented PFS Results in ALK-Positive Lung Cancer Trialѻýҕl> "We have not seen anything close to this," says expert May 31, 2024
<ѻýҕl>Smoking Isn't the Only Source of Nicotine Addiction in Townѻýҕl> Emerging data suggest pharmacological interventions may help patients quit vaping May 29, 2024
<ѻýҕl>Psychostimulant No Help in Relieving Cancer-Related Fatigueѻýҕl> No significant differences in outcomes between methylphenidate, placebo May 22, 2024
<ѻýҕl>FDA OKs Novel BiTE Agent for Small Cell Lung Cancerѻýҕl> First-in-class tarlatamab achieved a 40% ORR in previously treated extensive-stage SCLC May 16, 2024
<ѻýҕl>Perioperative Nivolumab Boosts EFS in Resectable Lung Cancerѻýҕl> CheckMate 77T trial shows 42% reduction in risk of tumor recurrence, progression, or death May 15, 2024
<ѻýҕl>Will AI Replace Radiologists, or Just Make Them Better Than Ever?ѻýҕl> Opinions differ on how much physicians should be embracing the technology May 14, 2024
<ѻýҕl>Glecirasib Shows Promising Efficacy in KRAS-Mutated NSCLCѻýҕl> Trend towards better response rate, PFS compared with approved KRAS inhibitors May 01, 2024
<ѻýҕl>EPA Bans Consumer Use of Toxic Chemical Known to Cause Liver, Lung Cancersѻýҕl> Methylene chloride has killed at least 88 workers since 1980 Apr 30, 2024
<ѻýҕl>White House Indefinitely Delays Plan to Ban Menthol Cigarettesѻýҕl> Biden administration has delayed the final rule several times recently Apr 26, 2024
<ѻýҕl>Alectinib Lands FDA Approval for Adjuvant Therapy in NSCLCѻýҕl> The ALK inhibitor reduced the risk of recurrence or death by 76% versus chemotherapy Apr 19, 2024
<ѻýҕl>Accelerated Aging Linked to Recent Increase in Early-Onset Solid Tumorsѻýҕl> Strength of association increased in more recent birth cohorts Apr 09, 2024
<ѻýҕl>Can Late-Stage Cancer Incidence Serve as an Endpoint for Screening Trials?ѻýҕl> Study shows it may be an alternative to cancer-specific mortality for some cancers, but not all Apr 08, 2024
<ѻýҕl>Enhertu Gets Tumor-Agnostic FDA Approval for HER2-Positive Cancersѻýҕl> About half of patients responded, duration of response as long as 19 months in three trials Apr 05, 2024
<ѻýҕl>Forget 'Pack-Years' for Lung Cancer Screening Eligibility, Study Suggestsѻýҕl> Switching to just a 20-year duration of smoking could catch more cancers, eliminate disparities Apr 01, 2024
<ѻýҕl>Graphic Images on Cigarettes of Smoking's Harm Are Constitutional, Court Rulesѻýҕl> Partial victory for federal regulators seeking to toughen warning labels Mar 22, 2024
<ѻýҕl>EPA Bans Asbestos, a Deadly Carcinogen Still in Use Decades After Partial Banѻýҕl> New rule would prohibit chrysotile asbestos Mar 19, 2024
<ѻýҕl>First-Line Immunotherapy Alone Sufficient for Older NSCLC Patients, Study Suggestsѻýҕl> Retrospective analysis finds similar OS, PFS whether or not patients also received chemotherapy Mar 07, 2024
<ѻýҕl>FDA OKs Amivantamab as First-Line Lung Cancer Treatmentѻýҕl> Bispecific drug lands full approval for NSCLCs with EGFR exon 20 insertion mutations Mar 04, 2024
<ѻýҕl>Changing the Surgical Paradigm in Oligometastatic NSCLCѻýҕl> Propensity-score matched analysis suggests survival benefit with surgery to the primary tumor Feb 23, 2024
<ѻýҕl>Another COVID Toll: Over 134,000 Undiagnosed Cancers During Height of Pandemicѻýҕl> Diagnosis rates remained low throughout 2020, with mortality increase projected Feb 22, 2024
<ѻýҕl>Arginine Starvation Boosts OS in Mesotheliomaѻýҕl> With frontline immunotherapy now standard, strategy could potentially find home in second-line Feb 16, 2024
<ѻýҕl>Perioperative Tislelizumab Demonstrates Survival Benefit in NSCLCѻýҕl> But how well will the results from China translate to Western populations? Feb 16, 2024
<ѻýҕl>Tepotinib Gains Full Approval for Metastatic NSCLCѻýҕl> Agency converts accelerated approval for subset with MET exon 14 mutations Feb 16, 2024
<ѻýҕl>Smokers Who Quit and Stick With It See Greatest Reduction in Cancer Riskѻýҕl> Cessation at any age proved helpful for lowering cancer risk Feb 06, 2024
<ѻýҕl>Patients and Doctors Push Back Against the Harsh Side Effects of Cancer Drugsѻýҕl> "If the patients are not taking the drug, then it's not going to work" Feb 06, 2024
<ѻýҕl>Camp Lejeune Water Contamination Tied to a Range of Cancers, CDC Study Saysѻýҕl> Health risks now more firmly established, but study falls short of being definitive Feb 01, 2024
<ѻýҕl>Pushback on Rule for Surgical Lymph Node Sampling During Lung Resectionѻýҕl> Surgeons debate the right standard for lymph node dissection in lung cancer Jan 31, 2024